Pavmed Inc (PAVM)

Apr 03, 2025

Lucid Diagnostics to Participate in Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference - BioSpace

Apr 03, 2025

Mar 31, 2025

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Mar 31, 2025

Mar 31, 2025

PAVmed outlines strategic milestones for 2025, including Veris implantable device submission - MSN

Mar 31, 2025

Mar 30, 2025

Pavmed’s Strategic Growth and Financial Challenges - MSN

Mar 30, 2025

Mar 29, 2025

PAVmed Inc. (NASDAQ:PAVM) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 29, 2025

Mar 27, 2025

Lucid Diagnostics Launches "Embrace the Future" Campaign Showcasing EsoCheck's Groundbreaking Collect+Protect Esophageal Cell Collection Technology - PR Newswire

Mar 27, 2025

Mar 26, 2025

PAVmed Inc (PAVM) Q4 2024 Earnings Call Highlights: Strategic Growth and Financial Stability - Yahoo

Mar 26, 2025

Mar 26, 2025

PAVmed Inc (PAVM) Q4 2024 Earnings Call Highlights: Strategic Gr - GuruFocus.com

Mar 26, 2025

Mar 26, 2025

PAVmed Reports Strong Q4 Results and Strategic Progress - TipRanks

Mar 26, 2025

Mar 25, 2025

Earnings call transcript: PAVmed Q4 2024 reports net income boost - Investing.com India

Mar 25, 2025

Mar 25, 2025

Earnings call transcript: PAVmed Q4 2024 reports net income boost By Investing.com - Investing.com South Africa

Mar 25, 2025

Mar 25, 2025

PAVmed Inc Surpasses Q4 2024 Revenue Estimates with $1.2 Million, Driven by Record EsoGuard Test Volume - GuruFocus

Mar 25, 2025

Mar 25, 2025

PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results - Placera.se

Mar 25, 2025

Mar 25, 2025

PAVmed Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 25, 2025

Mar 25, 2025

PAVmed Achieves Triple Win: Record Tests, Insurance Coverage, Positive Income - Stock Titan

Mar 25, 2025

Mar 25, 2025

Lucid Diagnostics Reports Strong Growth and Future Plans - TipRanks

Mar 25, 2025

Mar 24, 2025

Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results - PR Newswire

Mar 24, 2025

Mar 20, 2025

Lucid Diagnostics Announces Updated National Comprehensive Cancer Network® (NCCN) Guidelines Now Include Esophageal Precancer Screening - The Malaysian Reserve

Mar 20, 2025

Mar 20, 2025

Lucid Diagnostics Announces Updated National Comprehensive Cance - GuruFocus

Mar 20, 2025

Mar 20, 2025

Major Breakthrough: NCCN Backs New Esophageal Cancer Testing Method, Insurance Coverage Expected to Expand - Stock Titan

Mar 20, 2025

Mar 19, 2025

Lucid Diagnostics' ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication - BioSpace

Mar 19, 2025

Mar 18, 2025

Lucid Diagnostics' ENVET-BE Clinical Utility Study of EsoGuard® - GuruFocus.com

Mar 18, 2025

Mar 18, 2025

Clinical Study: New EsoGuard Test Detects Esophageal Cancer Risk 140% More Effectively - StockTitan

Mar 18, 2025

Mar 13, 2025

Lucid Diagnostics Secures First Positive Commercial Insurance Coverage Policy for its EsoGuard® Esophageal DNA Test - The Malaysian Reserve

Mar 13, 2025

Mar 13, 2025

Lucid Diagnostics Secures First Positive Commercial Insurance Coverage Policy for its EsoGuard® Esophageal DNA Test – Company AnnouncementFT.com - Financial Times

Mar 13, 2025

Mar 13, 2025

Major Breakthrough: Lucid Diagnostics Secures Game-Changing Insurance Coverage for Cancer Test - Stock Titan

Mar 13, 2025

Mar 11, 2025

Lucid Diagnostics Executes First Concierge Medicine Contract wit - GuruFocus.com

Mar 11, 2025

Mar 11, 2025

Lucid Diagnostics Regains Compliance with Nasdaq Minimum Bid Pri - GuruFocus.com

Mar 11, 2025

Mar 11, 2025

PAVmed to Hold a Business Update Conference Call and Webcast on March 25, 2025 - Longview News-Journal

Mar 11, 2025

Mar 11, 2025

PAVmed CEO to Reveal Growth Strategy and Q4 Results in Upcoming Investor Call - Stock Titan

Mar 11, 2025

Mar 10, 2025

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 24, 2025 - BioSpace

Mar 10, 2025

Mar 07, 2025

Midtown company tells investors esophageal pre-cancer screening should be an easier pill to swallow - Crain's New York Business

Mar 07, 2025

Mar 06, 2025

PAVmed, Inc. to Host Earnings Call - ACCESS Newswire

Mar 06, 2025

Mar 06, 2025

Lucid Diagnostics Announces Closing of $15.3 Million Registered Direct Offering - BioSpace

Mar 06, 2025

Mar 05, 2025

Lucid Diagnostics secures $15.3 million in stock offering By Investing.com - Investing.com Australia

Mar 05, 2025

Mar 05, 2025

Lucid Diagnostics secures $15.3 million in stock offering - Investing.com

Mar 05, 2025

Mar 05, 2025

Lucid Diagnostics secures $15.3 million in stock sale By Investing.com - Investing.com Australia

Mar 05, 2025

Mar 05, 2025

Lucid Diagnostics Announces $15.3 Million Registered Direct Offering - The Eastern Progress Online

Mar 05, 2025

Mar 05, 2025

SEC Form 424B5 filed by Lucid Diagnostics Inc. - Quantisnow

Mar 05, 2025

Mar 05, 2025

Insulet (NASDAQ:PODD) & PAVmed (NASDAQ:PAVM) Head-To-Head Review - Defense World

Mar 05, 2025

Mar 04, 2025

Lucid Diagnostics Announces $15.3 Million Registered Direct Offe - GuruFocus.com

Mar 04, 2025

Mar 04, 2025

Lucid Diagnostics ends "at the market" equity offering By Investing.com - Investing.com South Africa

Mar 04, 2025

Mar 04, 2025

Lucid Diagnostics ends "at the market" equity offering - Investing.com India

Mar 04, 2025

Mar 04, 2025

Lucid Diagnostics secures $15.3 million in stock sale - Investing.com

Mar 04, 2025

Mar 03, 2025

PAVmed Inc. (NASDAQ:PAVM) Short Interest Update - Defense World

Mar 03, 2025

Feb 28, 2025

Tasso Partners Reports 18.9% Passive Stake In PAVmed As Of Feb 21SEC Filing - Marketscreener.com

Feb 28, 2025